bullish
Presentation for Webinar: 2021 High Conviction-Investment Opportunities in China Healthcare Industry
651 Views14 Jan 2021 20:27
SUMMARY
The presentation for Webinar: 2021 High Conviction - Investment Opportunities in China Healthcare Industry would mainly include the following parts:
- Stock performance review
- Market review
- Logic behind the rally of the stock price
- Investment trend in 2021
- Q&A
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Bloomage Biotechnology (688363.CH) - Accelerated Growth with the Approval of New Regulation21 Jan 2021
- Wuxi Biologics (2269 HK) - A Monopoly in China Macromolecule CDMO20 Jan 2021
- Hygeia Healthcare Group (6078 HK) - Good Business Model with Large Market Potential19 Jan 2021
- Presentation for Webinar: 2021 High Conviction-Investment Opportunities in China Healthcare Industry14 Jan 2021
- China Healthcare Policy Update - The Official Results of 2020 Medical Insurance Negotiations04 Jan 2021
- JD Health (6618.HK) - Opportunities Coexist with Challenges15 Dec 2020
- 2021 High Conviction - Investment Opportunities in China Healthcare Industry23 Nov 2020
x